NASDAQ · Medical - Healthcare Information Services

Accolade, Inc. (ACCD) Stock

$7.02 +0.00% NASDAQ: ACCD Healthcare

Accolade, Inc., along with its subsidiaries, specializes in providing innovative, technology-driven solutions across the United States. These solutions are designed to empower individuals to better understand, navigate, and ultimately leverage both the complex healthcare system and their available workplace benefits.

Valuation

MetricValue
Price$7.02
Market Cap$575.59M
P/E Ratio-5.28
P/B Ratio1.18
P/S Ratio1.39
EPS (TTM)$-1.33
52-Week High$9.67
52-Week Low$3.08
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-21.71%
ROA-12.66%
ROCE-16.82%
Gross Margin46.36%
Operating Margin-27.63%
Net Margin-24.09%
Debt/Equity0.54
Current Ratio2.64

Annual Financials (USD)

Metric20202021202220232024
Revenue$133.0M$170.0M$310.0M$363.0M$414.0M
Operating Profit$-48.0M$-47.0M$-171.0M$136.0M$-114.0M
Net Profit$-51.0M$-51.0M$-123.0M$-460.0M$-100.0M
EPS$-1.05$-0.87$-1.93$-6.45$-1.33
Op Margin-36.4%-27.5%-55.2%37.4%-27.6%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$124.0M$476.0M$1.3B$903.0M$788.0M
Total Liabilities$148.0M$85.0M$430.0M$429.0M$343.0M
Cash$84.0M$434.0M$366.0M$321.0M$186.0M
Borrowings$72.0M$0$320.0M$317.0M$242.0M

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-34.0M$-25.0M$-62.0M$-41.0M$-16.0M
Investing Cash Flow$-7.0M$-5.0M$-268.0M$-20.0M$-76.0M
Financing Cash Flow$7.0M$451.0M$-30.0M$3.0M$0
Net Cash Flow$-10.0M$401.0M$-68.0M$-45.0M$-135.0M
Free Cash Flow$-38.0M$-28.0M$-66.0M$-48.0M$-29.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.04
EV / EBITDA-9.11
FCF Yield-4.98%
Quick Ratio2.79
Interest Coverage-39.89
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APENApollo Endosurgery, Inc. $10.00 +0.00% -10.20 $579.72M 0.00%
BDSIBioDelivery Sciences International, Inc. $5.59 -0.09% 6.82 $577.05M 0.00%
CTEVClaritev Corporation $21.73 +0.56% -1.25 $370.45M 0.00%
EXAIExscientia plc $4.84 — -3.06 $633.18M 0.00%
MPLNMultiPlan Corporation $23.15 -1.53% -1.34 $374.98M 0.00%

About Accolade, Inc.

Accolade, Inc., along with its subsidiaries, specializes in providing innovative, technology-driven solutions across the United States. These solutions are designed to empower individuals to better understand, navigate, and ultimately leverage both the complex healthcare system and their available workplace benefits. At the core of its offering is a robust cloud-based platform that delivers comprehensive, multimodal support. This assistance comes from a dedicated team of health assistants and clinical professionals, including registered nurses, physician medical directors, and specialists in behavioral health. Furthermore, Accolade extends its services to include valuable second opinion consultations and crucial decision-making support for healthcare matters. The company primarily serves employers who aim to furnish their employees and their families with a unified, easily accessible resource for all their health, medical care, and benefits-related inquiries. Established in 2007, Accolade, Inc. maintains its corporate headquarters in Plymouth Meeting, Pennsylvania.

Accolade, Inc. is headquartered in US.

Accolade, Inc. (ACCD) stock trades at $7.02 with a market capitalization of $575.59M. The stock is valued at a price-to-earnings (P/E) ratio of -5.28, price-to-book of 1.18, price-to-sales of 1.39. Over the past 52 weeks the stock has ranged between $3.08 and $9.67, and currently trades 27.4% below its 52-week high.

On profitability, Accolade, Inc. generates a return on equity (ROE) of -21.71%, return on capital employed of -16.82%, an operating margin of -27.63%, a net profit margin of -24.09%.

Official website: www.accolade.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides